Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aschan

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Gene Therapy|September 28, 2007
OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 hA Treschow, C Unger, A Aints, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1989
Influenza B in transplant patientsJ Aschan, O Ringdén, P Ljungman, et al.
Bone Marrow Transplantation|October 19, 2004
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipientsP Ljungman, J Aschan, B Gustafsson, et al.
Experimental Hematology|October 12, 2000
Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distributionS Carlens, M Gilljam, M Remberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1993
Influenza A in immunocompromised patientsP Ljungman, J Andersson, J Aschan, et al.
Bone Marrow Transplantation|July 25, 1998
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantationM Remberger, O Ringdén, P Ljungman, et al.
Bone Marrow Transplantation|September 1, 1996
Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patientsP Ljungman, G Oberg, J Aschan, et al.
Bone Marrow Transplantation|May 9, 2000
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantationO Ringdén, M Remberger, S Lehmann, et al.
Bone Marrow Transplantation|September 25, 2007
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantationA Bjorklund, J Aschan, M Labopin, et al.
Bone Marrow Transplantation|July 3, 2003
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IVM Remberger, N Naseh, J Aschan, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Gene Therapy|September 28, 2007
OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 hA Treschow, C Unger, A Aints, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1989
Influenza B in transplant patientsJ Aschan, O Ringdén, P Ljungman, et al.
Bone Marrow Transplantation|October 19, 2004
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipientsP Ljungman, J Aschan, B Gustafsson, et al.
Experimental Hematology|October 12, 2000
Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distributionS Carlens, M Gilljam, M Remberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1993
Influenza A in immunocompromised patientsP Ljungman, J Andersson, J Aschan, et al.
Bone Marrow Transplantation|July 25, 1998
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantationM Remberger, O Ringdén, P Ljungman, et al.
Bone Marrow Transplantation|September 1, 1996
Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patientsP Ljungman, G Oberg, J Aschan, et al.
Bone Marrow Transplantation|May 9, 2000
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantationO Ringdén, M Remberger, S Lehmann, et al.
Bone Marrow Transplantation|September 25, 2007
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantationA Bjorklund, J Aschan, M Labopin, et al.
Bone Marrow Transplantation|July 3, 2003
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IVM Remberger, N Naseh, J Aschan, et al.
Pageof 7